Title:
POLYPEPTIDE COMPOUND FOR INHIBITING ANGIOGENESIS AND TUMOR GROWTH AND ITS APPLICATION
Document Type and Number:
Japanese Patent JP2011256179
Kind Code:
A
Abstract:
To provide a polypeptide that inhibits activity of EphB4 or EphrinB2 and is useful for treating a cancer or angiogenesis-related disease.
A soluble polypeptide comprises an amino acid sequence of an extracellular domain of an EphB4 protein and is isolated. The soluble polypeptide is prepared as a monomer and a fusion protein, and inhibits the signaling that results from interaction between EphB4 and EphrinB2.
More Like This:
WO/2005/040191 | CCN1 COMPOSITIONS AND METHODS |
JP2002530273 | Title of Invention A novel inhibitor of angiogenesis and tumor growth |
WO/2016/120307 | NOVEL PROTEINS SPECIFIC FOR ANGIOGENESIS |
Inventors:
KRASNOPEROV VALERY
ZOZULYA SERGEY
KERETESZ NATHALIE
REDDY RAMACHANDRA
GILL PARKASH
ZOZULYA SERGEY
KERETESZ NATHALIE
REDDY RAMACHANDRA
GILL PARKASH
Application Number:
JP2011157200A
Publication Date:
December 22, 2011
Filing Date:
July 15, 2011
Export Citation:
Assignee:
VASGENE THERAPEUTICS INC
International Classes:
C07K14/515; A61K8/64; A61K38/00; A61K48/00; A61P9/00; A61P35/00; C07H21/02; C07H21/04; C07K5/00; C07K14/705; C07K14/715; C07K16/18; C07K16/28; C07K16/30; C07K19/00; C12N15/09; C12N15/113; C12Q1/68; G01N33/53; A61K
Domestic Patent References:
JPH10501701A | 1998-02-17 | |||
JP2006521111A | 2006-09-21 |
Foreign References:
WO2002026827A1 | 2002-04-04 | |||
WO2003004057A1 | 2003-01-16 | |||
WO2003000113A2 | 2003-01-03 |
Attorney, Agent or Firm:
Axis International Patent Business Corporation